-
Something wrong with this record ?
A cell-free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs
E. Filová, M. Rampichová, A. Litvinec, M. Držík, A. Míčková, M. Buzgo, E. Košťáková, L. Martinová, D. Usvald, E. Prosecká, J. Uhlík, J. Motlík, L. Vajner, E. Amler,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT12156
MZ0
CEP Register
- MeSH
- Cell Differentiation MeSH
- Bone Marrow Cells cytology MeSH
- Chondrocytes cytology MeSH
- Fibrin chemistry MeSH
- Fibroblast Growth Factor 2 administration & dosage MeSH
- Insulin administration & dosage MeSH
- Collagen Type I chemistry MeSH
- Hyaluronic Acid chemistry MeSH
- Liposomes MeSH
- Mesenchymal Stem Cells cytology MeSH
- Swine, Miniature MeSH
- Elastic Modulus MeSH
- Nanofibers administration & dosage chemistry MeSH
- Polyvinyl Alcohol chemistry MeSH
- Swine MeSH
- Bone Regeneration * MeSH
- Tissue Scaffolds MeSH
- Cell Survival MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The aim of the study was to evaluate the effect of a cell-free hyaluronate/type I collagen/fibrin composite scaffold containing polyvinyl alcohol (PVA) nanofibers enriched with liposomes, basic fibroblast growth factor (bFGF) and insulin on the regeneration of osteochondral defects. A novel drug delivery system was developed on the basis of the intake effect of liposomes encapsulated in PVA nanofibers. Time-controlled release of insulin and bFGF improved MSC viability in vitro. Nanofibers functionalized with liposomes also improved the mechanical characteristics of the composite gel scaffold. In addition, time-controlled release of insulin and bFGF stimulated MSC recruitment from bone marrow in vivo. Cell-free composite scaffolds containing PVA nanofibers enriched with liposomes, bFGF, and insulin were implanted into seven osteochondral defects of miniature pigs. Control defects were left untreated. After 12 weeks, the composite scaffold had enhanced osteochondral regeneration towards hyaline cartilage and/or fibrocartilage compared with untreated defects that were filled predominantly with fibrous tissue. The cell-free composite scaffold containing PVA nanofibers, liposomes and growth factors enhanced migration of the cells into the defect, and their differentiation into chondrocytes; the scaffold was able to enhance the regeneration of osteochondral defects in minipigs.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031535
- 003
- CZ-PrNML
- 005
- 20191021094853.0
- 007
- ta
- 008
- 131002s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2013.02.056 $2 doi
- 035 __
- $a (PubMed)23499757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Filová, Eva $u Institute of Experimental Medicine of the ASCR, Vídenská 1083, 142 20 Prague, Czech Republic. evafil@biomed.cas.cz $7 xx0171464
- 245 12
- $a A cell-free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs / $c E. Filová, M. Rampichová, A. Litvinec, M. Držík, A. Míčková, M. Buzgo, E. Košťáková, L. Martinová, D. Usvald, E. Prosecká, J. Uhlík, J. Motlík, L. Vajner, E. Amler,
- 520 9_
- $a The aim of the study was to evaluate the effect of a cell-free hyaluronate/type I collagen/fibrin composite scaffold containing polyvinyl alcohol (PVA) nanofibers enriched with liposomes, basic fibroblast growth factor (bFGF) and insulin on the regeneration of osteochondral defects. A novel drug delivery system was developed on the basis of the intake effect of liposomes encapsulated in PVA nanofibers. Time-controlled release of insulin and bFGF improved MSC viability in vitro. Nanofibers functionalized with liposomes also improved the mechanical characteristics of the composite gel scaffold. In addition, time-controlled release of insulin and bFGF stimulated MSC recruitment from bone marrow in vivo. Cell-free composite scaffolds containing PVA nanofibers enriched with liposomes, bFGF, and insulin were implanted into seven osteochondral defects of miniature pigs. Control defects were left untreated. After 12 weeks, the composite scaffold had enhanced osteochondral regeneration towards hyaline cartilage and/or fibrocartilage compared with untreated defects that were filled predominantly with fibrous tissue. The cell-free composite scaffold containing PVA nanofibers, liposomes and growth factors enhanced migration of the cells into the defect, and their differentiation into chondrocytes; the scaffold was able to enhance the regeneration of osteochondral defects in minipigs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buňky kostní dřeně $x cytologie $7 D001854
- 650 12
- $a regenerace kostí $7 D001861
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a chondrocyty $x cytologie $7 D019902
- 650 _2
- $a kolagen typu I $x chemie $7 D024042
- 650 _2
- $a modul pružnosti $7 D055119
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrin $x chemie $7 D005337
- 650 _2
- $a fibroblastový růstový faktor 2 $x aplikace a dávkování $7 D016222
- 650 _2
- $a kyselina hyaluronová $x chemie $7 D006820
- 650 _2
- $a inzulin $x aplikace a dávkování $7 D007328
- 650 _2
- $a liposomy $7 D008081
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $7 D059630
- 650 _2
- $a nanovlákna $x aplikace a dávkování $x chemie $7 D057139
- 650 _2
- $a polyvinylalkohol $x chemie $7 D011142
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a miniaturní prasata $7 D013556
- 650 _2
- $a tkáňové podpůrné struktury $7 D054457
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rampichová, Michala $u - $7 xx0171325
- 700 1_
- $a Litvinec, Andrej $u - $7 xx0239124
- 700 1_
- $a Držík, Milan $u -
- 700 1_
- $a Míčková, Andrea $u -
- 700 1_
- $a Buzgo, Matej $u - $7 xx0255533
- 700 1_
- $a Kuželová Košťáková, Eva $u - $7 xx0073449
- 700 1_
- $a Martinová, Lenka $u -
- 700 1_
- $a Usvald, Dušan $u - $7 xx0110082
- 700 1_
- $a Prosecká, Eva $u - $7 xx0171465
- 700 1_
- $a Uhlík, Jiří, $u - $d 1966- $7 jn20010309782
- 700 1_
- $a Motlík, Jan, $u - $d 1946- $7 ola200208047
- 700 1_
- $a Vajner, Luděk, $d 1954- $7 jn20010309783
- 700 1_
- $a Amler, Evžen, $u - $d 1958- $7 xx0014074
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 447, č. 1-2 (2013), s. 139-149
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23499757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20191021095326 $b ABA008
- 999 __
- $a ok $b bmc $g 995622 $s 829980
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 447 $c 1-2 $d 139-149 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- GRA __
- $a NT12156 $p MZ0
- LZP __
- $a Pubmed-20131002